Health Care: Drugs

Opexa Therapeutics Inc (OPXA: NASDAQ)

$0.66 -0.0124 | -1.84%
05/25/17 - 12:10 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 2.91M 2.56M 1.27M 1.27M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 2.91M 2.56M 1.27M 1.27M
Selling, General, and Administrative Expenses 3.12M 4.26M 3.83M 3.67M
Research & Development 6.50M 10.04M 12.12M 9.18M
Operating Income before D & A (EBITDA) -6.71M -11.74M -14.68M -11.59M
Depreciation & Amortization 238.13K 351.40K 387.78K 2.07M
Interest Income 874.00 5.91K 13.47K 14.98K
Other Income - Net 8.31K 67.53K 2.15K -2.48M
Special Income / Charges -1.04M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -7.98M -12.02M -15.05M -16.13M
Interest Expense 0.00 0.00 0.00 2.27M
Pre-Tax Income -7.98M -12.02M -15.05M -18.39M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -7.98M -12.02M -15.05M -16.66M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -7.98M -12.02M -15.05M -16.66M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -7.98M -12.02M -15.05M -16.66M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-6.94M -12.02M -15.05M -16.66M
Preferred Dividends
Net Income Available To Common -7.98M -12.02M -15.05M -16.66M
Basic EPS from Continuing Ops. -1.13 -2.05 -4.33 -8.85
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.13 -2.05 -4.33 -8.85
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.13 -2.05 -4.33 -8.85
Basic Normalized Net Income/Share -0.98 -2.05 -4.33 -8.85
EPS fr Continuing Ops. -1.13 -2.05 -4.33 -8.85
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.13 -2.05 -4.33 -8.85
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.13 -2.05 -4.33 -8.85
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.98 -2.05 -4.33 -8.85
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with OPXA

Latest OPXA Headlines from TheStreet

More Financial News for OPXA

Press Releases for OPXA

See All Press Releases

Partner Headlines for OPXA

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter